|
BAZ1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.50529613615913E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.16950002196859E-09 |
| Normal-vs-Stage2 |
1.750860E-04 |
| Normal-vs-Stage3 |
2.6480000000495E-06 |
| Normal-vs-Stage4 |
1.378090E-04 |
| Stage1-vs-Stage2 |
6.516800E-01 |
| Stage1-vs-Stage3 |
1.277220E-01 |
| Stage1-vs-Stage4 |
8.016400E-01 |
| Stage2-vs-Stage3 |
4.826600E-01 |
| Stage2-vs-Stage4 |
9.350400E-01 |
| Stage3-vs-Stage4 |
5.160000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44840028859505E-10 |
| Normal-vs-AfricanAmerican |
5.92529999510205E-08 |
| Normal-vs-Asian |
6.711800E-02 |
| Caucasian-vs-AfricanAmerican |
6.860000E-01 |
| Caucasian-vs-Asian |
4.659600E-01 |
| AfricanAmerican-vs-Asian |
3.263800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.45010045374761E-10 |
| Normal-vs-Female |
4.50769976900744E-10 |
| Male-vs-Female |
5.464400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.55070000000302E-05 |
| Normal-vs-Extreme_Weight |
7.69229999697529E-08 |
| Normal-vs-Obese |
9.16590026101005E-10 |
| Normal-vs-Extreme_Obese |
4.299100E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.833600E-01 |
| Normal_Weight-vs-Obese |
9.380300E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.820000E-01 |
| Extreme_Weight-vs-Obese |
4.194000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.614800E-01 |
| Obese-vs-Extreme_Obese |
1.970550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.558170E-04 |
| Normal-vs-Age(41-60Yrs) |
3.07687209044616E-12 |
| Normal-vs-Age(61-80Yrs) |
1.2469999999265E-07 |
| Normal-vs-Age(81-100Yrs) |
4.274100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.204400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.199570E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.377000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.357600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.215510E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.914800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.00619520995815E-11 |
| Normal-VS-Type2 PRCC |
6.06469999999693E-05 |
| Normal-VS-KIRP CIMP |
4.942300E-03 |
| Normal-VS-Unclassified PRCC |
4.82049999994683E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.375600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.325170E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.722200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.898400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.278400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.172770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.88169999995702E-06 |
| Normal-vs-N1 |
4.97990000014603E-07 |
| Normal-vs-N2 |
2.292600E-01 |
| N0-vs-N1 |
1.439930E-03 |
| N0-vs-N2 |
3.213600E-01 |
| N1-vs-N2 |
4.943700E-02 |
|
|
